Yes, idiopathic pulmonary fibrosis (IPF) is a terminal illness. This condition is a chronic, progressive disorder in which the tissue of the lungs becomes thick and stiff, making it difficult for the lungs to exchange oxygen with the air. Over time, the condition worsens, leading to impaired breathing and an increased risk of infection.
IPF is a terminal illness because there is no cure yet. Treatment is largely focused on managing symptoms and slowing the progression of the disease. Although some people may live with the condition for years, it is ultimately fatal for most patients. The average lifespan after diagnosis is between three and five years, though this can vary depending on a person’s age and other health conditions.
IPF is a serious condition that can be particularly challenging to diagnose. Symptoms such as shortness of breath, fatigue, and a dry cough are common, yet they can also overlap with other illnesses. It is important to see a doctor if you are experiencing these symptoms, as early diagnosis and treatment can help improve prognosis and quality of life.